NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support
November 01, 2023 04:00 ET
|
NorthX Biologics Matfors AB
NorthX Biologics AB Introduces Proprietary AAV Plasmids, Bolstering Comprehensive Gene Therapy Support
NorthX Biologics AB Announces Inauguration of Innovation Hub at Matfors Facility
September 28, 2023 03:00 ET
|
NorthX Biologics Matfors AB
NorthX Biologics AB is proud to announce the official inauguration of its state-of-the-art Innovation Hub at the Matfors facility.
Cell and Gene Therapy Manufacturing Services Market worth $26.72 Billion, Globally, by 2030 – Comprehensive Study by The Insight Partners
September 27, 2023 10:12 ET
|
The Insight Partners
Pune, India, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Cell & gene therapy (CGT) programs are rapidly advancing from research & development to clinical trials and commercial approval. Establishing...
Cell and Gene Therapy Manufacturing Quality Control (QC) Market to Reach USD 2.8 billion by 2031, Expanding at a CAGR of 24.6 % Says, Transparency Market Research
August 28, 2023 04:01 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global cell and gene therapy manufacturing quality control (QC) market is projected to...
NorthX Biologics Welcomes Dr Janet Hoogstraate as New CEO Following Merger with Valneva Clinical Trials Manufacturing Unit
August 23, 2023 04:00 ET
|
NorthX Biologics Matfors AB
MATFORS, Sweden, Aug. 23, 2023 (GLOBE NEWSWIRE) -- NorthX Biologics AB, (‘NorthX’), a leading Nordic development and manufacturing organisation with a focus on advanced biologics, CGT (cell and gene...
Cell and Gene Therapy Market to Worth Around USD 1,17,100 Million by 2032
August 10, 2023 11:50 ET
|
Precedence Research
Ottawa, Aug. 10, 2023 (GLOBE NEWSWIRE) -- The global cell and gene therapy market revenue is estimated to surpass around USD 45,700 million by 2028, a study published by Towards Healthcare a sister...
National Marrow Donor Program® (NMDP)/Be The Match® Names Christina Melief, Ph.D., Senior Scientific Advisor
July 25, 2023 17:01 ET
|
Be The Match
Dr. Melief will work to simplify and accelerate the acquisition of cord blood units for transplant and cell and gene therapies through expanded access for transplant centers, cord blood banks, and...
Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program
July 05, 2023 04:00 ET
|
AKAMPION
- Cellbox Solutions selected by the EIC following the second 2023 EIC Accelerator cut-off PRESS RELEASE. Cologne, Germany — July 05, 2023 - Cellbox Solutions GmbH, a leading provider of warm...
NorthX Biologics, ledande nordisk biofarmaceutisk tillverkare och innovationshubb, förvärvar avancerad tillverkningsenhet för kliniska prövningar från Valneva
July 03, 2023 08:00 ET
|
NorthX Biologics Matfors AB
MATFORS, Sverige, July 03, 2023 (GLOBE NEWSWIRE) -- NorthX Biologics ('NorthX'), en nordisk innovationshubb och ledande inom processutveckling och tillverkning av avancerade biologiska läkemedel,...
NorthX Biologics, a leading Nordic development and manufacturing organisation announces acquisition of a biologics manufacturing unit from Valneva
July 03, 2023 08:00 ET
|
NorthX Biologics Matfors AB
MATFORS, Sweden, July 03, 2023 (GLOBE NEWSWIRE) -- NorthX Biologics (‘NorthX’), a leading Nordic development and manufacturing organisation with a focus on advanced biologics, CGT (cell and gene...